The FDA on Monday issued new guidelines to doctors on how to treat thromboembolism (a clot that forms in the brain and blood vessels) without using drugs or surgery.
The FDA has been working to set up a national network of doctors who are trained in how to care for patients with thrombi and thrombus (blood clots) with specialized care, such as thrombosurgery.
The agency will also begin to provide training for physicians on how best to handle patients who have a thrombed on their heart, liver or lungs.
The new guidelines also give more clarity on when a doctor can begin to prescribe certain medications.
They will outline what medications are permitted to be used and how long the drugs can be kept in the patient’s system.
While some doctors have been saying they’re not ready to start prescribing the medication until doctors can be more trained to handle them, the FDA said doctors should have more time to learn how to prescribe the drug.
This could mean a few weeks or even a few months, but it could also mean months, the agency said.
Patients should always be informed of the potential side effects and other potential risks, and a doctor should be in charge of monitoring patients’ health.
The guidelines will help doctors get to know each other better, as they will be able to provide more guidance and discuss their patients’ medical needs, said FDA Commissioner Scott Gottlieb.
The agency is also making it clear that it is okay for a doctor to take a medication in the early stages of the disease, but not to prescribe it later.
The rules also make it clear for doctors to use common sense when prescribing certain drugs, such the blood thinners used to treat patients with blood clots.
For example, the guidelines will not permit doctors to prescribe aspirin to patients with a bleeding problem, and they will not allow doctors to administer antibiotics to patients.